Mr. Jackman is a director in the Biotechnology/Chemical Group. His practice includes counseling clients in areas such as global patent portfolio procurement and management strategies, FDA/ANDA practice, technology transfer, invalidity, noninfringement, freedom-to-operate and patentability opinions and due diligence investigations. He has also written and prosecuted patent applications domestically and internationally in areas such as immunology, genomics, molecular and cell biology, recombinant DNA technology, transgenics, bioprocessing, advanced biofuels, microbiology, therapeutic methods and food science. Mr. Jackman has further been involved in U.S. patent interference, reexamination and litigation matters as well as foreign oppositions.
Mr. Jackman is also a member of the firm's CleanTech Industry Group. He frequently lectures and publishes on intellectual property issues surrounding green technologies, and he was an Associate Editor for Clean Tech Law & Business, the first peer-reviewed journal devoted exclusively to the pursuit of environmentally sustainable technology.
